ConductScience.org, home

Comparison · NCT03668236-b2576284

Fluid Restriction Group vs Standard-care: Number of Participants With One or More Serious Adverse Reactions (SARs) to IV Crystalloids in the ICU.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Fluid Restriction Group vs Standard-care: Number of Participants With One or More Serious Adverse Reactions (SARs) to IV Crystalloids in the ICU. Trial comparisons, record NCT03668236-b2576284. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03668236-b2576284

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.04110.02910.0577wilson
Risk in group 20.04120.02940.0576wilson
Risk difference, group 1 minus group 2-0.000178-0.02050.0203newcombe hybrid score
Risk ratio, group 1 over group 20.9960.6141.62log
Odds ratio, group 1 over group 20.9960.6011.65log
Number needed to treat, for one fewer participant with the outcome on Fluid Restriction Group than on Standard-care5,630from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Fluid Restriction GroupNo IV fluids unless one of the extenuating circumstances occurred (additional details in protocol section)31755OG000
Group 2Standard-careNo upper limit for IV fluids (additional details in protocol section).32776OG001

Outcome

Type
SECONDARY
Title
Number of Participants With One or More Serious Adverse Reactions (SARs) to IV Crystalloids in the ICU.
Description
The pre-specified SARs to IV crystalloids were: Generalized tonic-clonic seizures, anaphylactic reactions, central pontine myelinolysis, severe hypernatremia, severe hyperchloremic acidosis, and severe metabolic alkalosis. Data on the outcome measures, including SARs, were obtained from patient medical records by the trial investigators or their delegates.
Time frame
Until ICU discharge, maximum 90 days
Population
All secondary outcome data were missing for 23 patients (15 patients in the restrictive-fluid group and 8 in the standard-fluid group).

Source ClinicalTrials.gov

Trial

Title
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
NCT number
NCT03668236
Phases
PHASE4
Conditions
Septic Shock
Interventions
Isotonic crystalloids
Lead sponsor
Anders Perner, MD, PhD
Results first posted
2025-02-24

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03668236-b2576284